Outpatient Management of Fever and Neutropenia in Low-risk Children with Solid Tumors: A Quality Improvement Initiative.

Autor: Bourgeois W; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Paolino J; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Garland R; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Campbell K; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Alvarez-Calderon F; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Frazier AL; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., O'Neill AF; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Ilowite M; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Wong CI; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass.; Division of Pediatric Hematology-Oncology, University Hospitals Rainbow Babies and Children's Hospital, Cleveland, Ohio.; Division of Hematology-Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Publikováno v: Pediatric quality & safety [Pediatr Qual Saf] 2024 Sep 25; Vol. 9 (5), pp. e771. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).

Tolerability of ifosfamide-containing regimen in patients with high-risk renal and INI-1-deficient tumors.

Autor: Wong CI; Division of Pediatric Hematology-Oncology, University Hospitals Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.; Division of Medical Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio, USA.; Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Benedetti DJ; Department of Pediatrics, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Kao PC; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Ma C; Centre for Addictions and Mental Health, Toronto, Ontario, Canada.; Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Marcus KJ; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Division of Radiation Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, USA., Mullen EA; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Aug; Vol. 70 (8), pp. e30422. Date of Electronic Publication: 2023 May 23.

Preventable harm because of outpatient medication errors among children with leukemia and lymphoma: A multisite longitudinal assessment.

Autor: Wong CI; Pediatric Hematology-Oncology, University Hospitals Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.; Medical Oncology, University Hospitals Seidman Cancer Center, Cleveland, Ohio, USA., Vannatta K; Center for Biobehavioral Health, Nationwide Children's Hospital, Columbus, Ohio, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA., Gilleland Marchak J; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Quade EV; Center for Biobehavioral Health, Nationwide Children's Hospital, Columbus, Ohio, USA., Rodgers IM; Division of General Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA., Reid CM; Department of Pediatrics, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Dandoy CE; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Billett AL; Quality and Safety Program, Nemours Children's Health, Delaware Valley, Wilmington, Delaware, USA., Miller TP; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Vaughn S; Department of Otolaryngology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Daraiseh NM; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Liu S; Biostatistics and Research Design Center, Boston Children's Hospital, Boston, Massachusetts, USA.; Institutional Centers for Clinical Translational Research, Boston Children's Hospital, Boston, Massachusetts, USA., Carle AC; Department of Pediatrics, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; College of Medicine University of Cincinnati, Cincinnati, Ohio, USA.; Department of Psychology, College of Arts and Sciences, University of Cincinnati, Cincinnati, Ohio, USA., Walsh KE; Division of General Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Cancer [Cancer] 2023 Apr 01; Vol. 129 (7), pp. 1064-1074. Date of Electronic Publication: 2023 Jan 27.

Cationic Antimicrobial Peptides Combine with Antibiotics for Liquid Boar Semen Preservation

Autor: WONG, CI-HONG, 翁齊宏

105
Antibiotics should be added to boar semen extender to increase semen storage time and reduce pathogen proliferation. Although antibiotics easily cause bacterial resistance, a lack of them in boar semen results in bacterial proliferation, a d

Externí odkaz: http://ndltd.ncl.edu.tw/handle/36990575708796073275

Emergency admission preceding malignancy diagnosis: Insights from a study at a tertiary care hospital.

Autor: Redha, Hussain A.¹ (AUTHOR), Al Hatmi, Kawther S.² (AUTHOR), Al-Ghaithi, Safa K.² (AUTHOR), Al Zeedy, Khalfan B.^1,3 (AUTHOR), Al Alawi, Abdullah M.^1,3 (AUTHOR) dr.abdullahalalawi@gmail.com

Publikováno v: Journal of Family & Community Medicine. Oct-Dec2024, Vol. 31 Issue 4, p295-304. 10p.